RecruitingNCT05911750

Prevalence and Clinical Implications of HPV Infection in Male IBD Patients

Prevalence and Clinical Implications of Human Papillomavirus Infection in the Male Population With Inflammatory Bowel Disease


Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Enrollment

384 participants

Start Date

Feb 12, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The study aims at describing the prevalence of Human Papillomavirus (HPV) infection in anal and oral samples of men with Inflammatory Bowel Disease (IBD) and detecting risk factors for the infection.


Eligibility

Sex: MALEMin Age: 18 YearsMax Age: 79 Years

Inclusion Criteria3

  • Diagnosed Crohn's disease or ulcerative colitis (at least 3 months before enrollment)
  • Male
  • Age from 18 to 79 years

Exclusion Criteria6

  • Unclassified Inflammatory Bowel Disease
  • Diarrhea (\> 3 bowel movements/day) with rectal bleeding at enrollment
  • Prior full proctectomy
  • Inability to collect the biological samples
  • Inability to complete the questionnaire
  • Refusal to sign the informed consent

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTAnal pap smear and oral swab for cytology and HPV testing

Anal and oral swab sampling for HPV detection (polymerase chain reaction) and cytology


Locations(1)

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Barcelona, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05911750


Related Trials